NCT02928159

Low Pulse Amplitude Seizure Therapy (LAP-ST Study)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Behman Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study assesses the feasibility of a full course of Low Pulse Amplitude-Seizure Therapy (LAP-ST) (primary outcome).

Detailed description

This is hypothesized to increase stimulation focality, thus minimizing cognitive side effects compared to conventional ECT. The study will enroll 22 patients recruited from the Behman Hospital, Cairo, Egypt. Patients referred to ECT service in the Behman Hospital who are clinically indicated to do ECT for major depressive episode of a mood disorder or psychotic episode of a primary psychotic disorder will be approached. Eligible participants who signed informed consent will be included to receive a course of Right Unilateral Ultrabrief LAP-ST.

Conditions

• Mood Disorders
• Schizophrenia Spectrum and Other Psychotic Disorders

Interventions

Type	Name	Description
DEVICE	Mecta spectrum 5000Q device	LAP-ST and Right Unilateral (RUL) electrode placement.

Timeline

• Start date: 2013-04-01
• Primary completion: 2015-06-01
• Completion: 2015-06-01
• First posted: 2016-10-10
• Last updated: 2016-10-10